Oral miltefosine in post-kala-azar dermal leishmaniasis--experience in three cases.
Khandpur
Sujay
S
Department of Dermatology & Venereology, All India Institute of Medical Sciences, New Delhi, India. sujaykhandpur@yahoo.co.in
Chaturvedi
Pankaj
P
Kumar
Uttam
U
Khaitan
Binod K
BK
Samantaray
Jyotish C
JC
Sharma
Vinod K
VK
D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016774:Leishmaniasis, Diffuse Cutaneous / Q000188:drug therapy* / Q000473:pathology; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D000981:Antiprotozoal Agents; D010767:Phosphorylcholine; C039128:miltefosine